Sign inJoin waitlistJoin the waitlist

Paul O'Brien

Assistant Professor, Division of Hematology and Oncology · Medical University of South Carolina College of Medicine

Credentials: · ·

History

Medical University of South Carolina College of Medicine
Present

Hematology and Medical Oncology
MUSC Medical Center
1999–2002
Internal Medicine
1996–1999
Feinberg School of Medicine
1992–1996

Research

Randomized Phase II Study of Duligotuzumab (MEHD7945A) vs. Cetuximab in Squamous Cell Carcinoma of the Head and Neck (MEHGAN Study)
Frontiers in Oncology · 2016 · 91 citations
Inhibition of mTOR Signaling and Clinical Activity of Rapamycin in Head and Neck Cancer in a Window of Opportunity Trial
Clinical Cancer Research · 2019 · 77 citations
Results of a phase II trial of gemcitabine plus doxorubicin in patients with recurrent head and neck cancers: serum C₁₈-ceramide as a novel biomarker for monitoring response
Clinical Cancer Research · 2011 · 57 citations

David Cole
3 papers
Keisuke Shirai
3 papers
Douglas Adkins
2 papers
LW
Lori Wirth
2 papers
Paul Baron
2 papers
Uzair Chaudhary
2 papers
Alberto Montero
1 paper · 1 as a resident
AC
Alfred Christie
1 paper
Amit Sood
1 paper · 1 as a resident
AS
Anand Sharma
1 paper
Antonio Jimeno
1 paper
Anvesh Kompelli
1 paper · 1 as a resident

Clinical trials

Neoadjuvant Folfirinox Followed by Capecitabine and Limited Field Radiation for Localized Pancreatic Head Adenocarcinoma
Principal investigator · Terminated · Phase 2
Medical University of South Carolina
2012
Gemcitabine and Doxorubicin in Treating Patients With Recurrent or Progressive Head and Neck Cancer
Principal investigator · Completed · Phase 2
Medical University of South Carolina
2005–2011